Main Content

Financials

Home / Investors / Financials
v3.19.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash $ 175,677 $ 102,698
Inventory 158,446 114,031
Total current assets 334,123 216,729
Tooling in process 173,854
Property and equipment, net 8,756 26,748
Other assets 8,983 18,983
Total assets 351,861 436,314
Current liabilities:    
Accounts payable 1,019,084 1,101,853
Customer deposits 80,587 69,330
Accrued liabilities 677,718 692,071
Current portion of leases payable 2,756 2,756
Due to related party 1,075 1,075
Convertible notes payable, current, net of debt discount 695,952 436,177
Derivative liability 2,947,927 1,222,186
Preferred shares liability 2,850,401 2,850,401
Warrant liability 906,112 6,267,426
Total current liabilities 9,181,612 12,643,275
Total liabilities 9,181,612 12,643,275
Redeemable Series B Preferred stock, $0.001 par value; 10,000,000 shares authorized 107,000 and 107,000 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 2,033,000 2,033,000
Stockholders' deficit:    
Series A Preferred stock, $0.001 par value; 51 shares authorized 51 and 51 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively
Common stock, $0.001 par value, 10,000,000,000 shares authorized; 4,814,093,774 and 3,905,200,946 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 4,814,093 3,905,201
Additional paid-in capital 22,619,271 21,820,069
Accumulated deficit (38,296,114) (39,965,231)
Total stockholders' deficit (10,862,751) (14,239,961)
Total liabilities and stockholders' deficit $ 351,861 $ 436,314

Source

v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Sales        
Product revenue $ 202,048 $ 53,375 $ 203,299 $ 204,280
Product service revenue 11,622 3,641 11,910 15,218
Licensing revenue 441 441 1,308 8,212
Total sales 214,111 57,457 216,517 227,710
Cost of goods sold        
Product costs 58,620 20,254 86,133 82,354
Total cost of sales 58,620 20,254 86,133 82,354
Gross profit 155,491 37,203 130,384 145,356
Operating Expenses        
Research and development 6,037 11,561 32,221 283,869
Sales and marketing 1,038 19,350 65,451 130,475
General and administrative (72,657) 245,174 460,233 803,103
Total operating expenses (65,582) 276,085 557,905 1,217,447
Income (loss) from operations 221,073 (238,882) (427,521) (1,072,091)
Other income (expense)        
Interest expense, net (215,591) (16,049) (688,850) (32,751)
Change in fair value of derivative liability (1,403,760) 625,074 (1,314,958) 1,817,014
Change in fair value of warrant liability 913,261 1,091,663 4,332,366 1,091,663
Derivative expense (163,033) (181,125) (281,515)
Loss on settlement of debt (4,500)
Gain (loss) on extinguishment of debt (17,712) (37,247)
Loss on impairment of assets (173,855) (173,855) 4,581
Gain (loss) on settlement of vendor liability 269,518 (5,235,869) 160,306 (5,235,869)
Total Other income (expense) (791,172) (3,539,681) 2,096,637 (2,636,877)
Income (Loss) before provision for income taxes (570,099) (3,778,563) 1,669,116 (3,708,968)
Provision for income taxes
Net income (loss) (570,099) (3,708,968) 1,669,116 (3,708,968)
Dividends (10,700) (32,100)
Net income (loss) attributable to common shareholders $ (580,799) $ (3,778,563) $ 1,637,016 $ (3,708,968)
Loss per share        
Basic $ (0.00) $ (0.00) $ 0.00 $ (0.00)
Diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average common shares outstanding - basic 4,709,633,820 3,873,380,471 4,151,099,739 2,931,417,714
Weighted average common shares outstanding - diluted 4,709,633,820 3,873,380,471 4,151,099,739 2,931,417,714

Source

v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income (loss) $ 1,669,116 $ (3,708,968)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 17,992 33,726
Change in fair value of derivative liability 1,314,958 (1,817,014)
Change in fair value of warrant liability (4,332,366) (1,091,663)
Principal Increase Upon Default 38,900
Derivative expense 181,125 281,515
(Gain) / Loss on settlement of vendor liabilities (160,306) 5,235,869
Stock based compensation (23,795) 360,846
Gain / (Loss) on extinguishment of debt 49,718 (4,581)
Loss on impairment of assets 173,854  
Interest expense related to amortization of debt issuance costs and debt discount 505,370 3,605
Changes in assets and liabilities:    
Inventory (44,415) 31,786
Prepaid expenses and other assets 10,000 25,204
Tooling in process (173,854)
Accounts payable and accrued liabilities 192,571 554,344
Customer deposits 11,257 20,756
Net cash used in operating activities (396,021) (248,429)
Cash flows from financing activities    
Proceeds from due to related party 105,000
Proceeds from the issuance of convertible notes payable,   55,000
Net of issuance costs 494,000
Repayment of convertible notes (25,000)  
Repayments on asset based loans
Net cash provided by financing activities 469,000 160,000
Net change in cash 72,979 (88,429)
Cash, beginning of period 102,698 119,028
Cash, end of period 175,677 30,599
Supplemental cash flow information:    
Interest paid
Taxes paid
Supplemental disclosure of non-cash investing and financing activities:    
Settlement of debt with convertible note 307,200 60,000
Stock issued for settlement of vendor liabilities 270,000 640,875
Conversion of debt 592,212
Conversion of convertible preferred stock to common stock 3,604,300
Reclassification of warrant liability to additional paid-in capital upon Exercise of warrant $ 845,883

Source